ARCHIVES

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Senate, House Budget Plans Likely To Result In Modest Funding Increases For NIH, NCI

May 11, 1990

Komen Brand Takes Hit After PR Disaster

March 30, 2012

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

Clinton Seeks Cut In NIH Increase

May 27, 1994